A Discernment and Apostasy watch site for African Saints.
Prove all things..(1 Thesa.5:21)
Test Spirits..(I John 4:1)
Like the Bereans, check whether things are so(Acts 17:11)
(KAMPALA) Today a civil
society coalition of more than 40 health rights organizations welcomed the
start of Constitutional Court’s hearing of Petition 16 of 2011. This health
rights case, filed on March 4, 2011 by the Centre for Health, Human Rights and
Development (CEHURD), was triggered by the preventable deaths of Jennifer Anguko
and Sylvia Nalubowa, two women who died while giving birth. The activists claim
that Uganda’s government is failing to fulfill fundamental rights guaranteed
under the Constitution, resulting in an epidemic of preventable deaths of
women.
Constitutional Court dismissed the petition in 2012, on the
grounds that the Court lacked standing to hear the case on its merits. CEHURD
appealed to the Supreme Court (Constitutional Appeal No. 1 of 2013) and on
September 30 2015 the Supreme Court ruled that Constitutional Court’s
dismissal was incorrect, and must hear the petition.
More than 16 women die daily
in Uganda from preventable causes including hemorrhage, sepsis, unsafe
abortion, obstructed labor, and pre-eclampsia. There has been no statistically
significant decrease in maternal mortality in Uganda for the last eight years
(source: Uganda Demographic and
Health Survey 2016 Key Indicators Report, page 58).
Uganda’s severely high rates of teenage pregnancy also contribute to
preventable maternal deaths—25% of young women 15-19 in Uganda is pregnant or a
mother, one of the highest rates in sub-Saharan Africa, a statistic that has
remained unchanged since 2006 (source: Uganda Demographic Health Survey, 2016).
The primary defense argued by Government
over the last 8 years the case has been in Court is that Uganda is too
poor to
fight maternal mortality effectively. Recent
evidence contradicts that claim: the FY2019/20Appropriations
Bill contains a 20.9% expansion in the overall budget compared with
FY2018/19.
The increase is largely for Security (increasing from 6.3% to 9.3% of
the
budget) and Works and Transport (increasing from 14.6% to 16.2%). The
Health budget share shrinks from 7.1% to 6.4%. By contrast,
“Classified Expenditure and Assets” increased dramatically from UShs 934
billion in FY2018/19 to UShs 2.582 trillion in FY2019/20—the same size
as the entire health budget.
Compounding the crisis caused by government under funding, are a
series of recent policy shifts. In 2018 Government shut down free
maternal health care services provided by Mulago National Referral
Hospital, and instead opened a USD25 million super specialized private
women’s clinic with no public wing. The private hospital charges
exorbitant user fees most pregnant women cannot afford. Although
government a decade ago pledged to provide emergency maternal health
care services at local level by equipping Health Center IVs with the
surgical theatres, health workers and commodities needed to save
pregnant women’s lives, that promise has been broken, forcing pregnant
women to rely on the national referral hospital.
The corrective actions being sought through this Constitutional Court
Petition would help remedy these gross inequities, according to the
advocates. “Deaths from maternal mortality could be largely eliminated
in Uganda,” said Noor Musisi of CEHURD. “What we are missing is
political will.”
Contact: Noor Nakibuuka Musisi, CEHURD 0782 496 681 or Asia Russell,
Health GAP 0776 574 729
How the death of two Ugandan mothers is helping entrench the right to health care
Executive Director at the Centre for Health, Human rights and Development and lecturer , Uganda Christian University
Disclosure statement
Moses Mulumba receives funding from the Open Society Foundation and IDRC-Canada.
When Sylvia Nalubowa went into labour in Uganda’s Mityana
district in August 2009, she was taken to a local health centre where
she expected to have a normal birth, supervised by a midwife.
After she had delivered her first baby the midwife realised there was
a twin on the way. The midwife recommended that Nalubowa be taken to
the district hospital where a doctor could handle the second delivery.
But when she arrived at the Mityana District Hospital in Central
Uganda, the nurses asked for her maternity kit. This is commonly known
as a “mama kit” and contains a plastic sheet, razor blades, cotton wool
or gauze pad, soap, gloves, cord ties, and a child health card. All
mothers delivering babies in Ugandan hospitals and clinics are expected
to bring their own “mama kits” when they go into labour.
But Nalubowa had used her “mama kit” at the first health facility
when delivering her first child. The nurses would hear none of her
excuses and demanded money to purchase the kit before they could attend
to her.
Nalubowa and her baby died.
Jennifer Anguko died under similar circumstances. She arrived at the
Arua hospital in North Western Uganda at 8.30am on December 10, 2010 but
was not attended to for 12 hours by which time her condition and cries
for help were out of control.
One hour later she was taken to theatre but she and her baby died
during the procedure. The cause of her death listed in the post mortem
report was a ruptured uterus.
The women’s cases are two of many
Sixteen women die in Uganda every day during child birth in instances that could be avoided. In 2011, the World Health Organisation reported that Uganda registers up to 440 deaths for every 100 000 live births.
This is unlike Rwanda where maternal mortality decreased by 77% between 2000 and 2013 and currently stands at 320 deaths for every 100 000 live births.
Most maternal deaths in Uganda are due to severe bleeding, infection,
hypertensive disorders and obstructed labour. Others are due to causes
such as malaria, diabetes, hepatitis and anaemia. All these are
aggravated by pregnancy.
The Ugandan government is committed to providing all citizens with
free health services. But it is common to go to a government health
facility and find that medicines are not in stock and health workers are
not paid. Patients also say that they are often met by health staff who
are unenthusiastic about attending to patients expecting free services.
In 2013, the doctor to patient ratio in Uganda was estimated at one doctor for just under 25 000 patients. The nurse to patient ratio sat at one nurse for 11 000 patients.
The country’s public health system has a tiered structure
with two national referral hospitals, 11 semi-autonomous regional
referral hospitals, and a well established district health system with
healthcare centres in 56 districts.
Health care services are financed
through general tax revenue and donor funding. Although user fees for
health services in public facilities were abolished in 2001 patients are
still expected to make direct out-of-pocket payments for some services
and drugs.
Fighting for a right
In 2011 lawyers at the Centre for health, Human Rights and Development,
a non-profit, research and advocacy organisation, began gathering
evidence to hold the Ugandan government to account for Nalubowa and
Anguko’s deaths.
The case is now before the country’s Constitutional Court.
In what has turned into a landmark case, the centre has argued that
failing to provide essential maternal health commodities in government
health facilities is an infringement on women’s rights. The rights to
life as well as health are guaranteed under the country’s constitution
as well as international human rights instruments the government has
signed up to. These include the:
International Covenant on Economic Social and Cultural Rights (ICESCR),
Convention of Elimination of All forms of Discrimination Against Women (CEDAW), and
At the first hearing before the Constitutional Court government
lawyers objected to the case. They argued that the judiciary was not competent to hear a case that required the executive arm of government to allocate resources to the health sector.
The court agreed and dismissed the case.
But the centre appealed to the Supreme Court, the highest court of
appeal in Uganda. It argued that the justices of the Constitutional
Court erred in denying them an opportunity to hear the case based on its
merits.
In October 2015 the Supreme Court’s seven judges agreed. They made a unanimous ruling
that the Constitutional Court judges had erred in dismissing the case.
In their judgment they argued that the case had key questions that
needed constitutional interpretation for the people of Uganda.
They contended that there is nothing the executive or legislature can
decide on that may not be subjected to judicial review - especially if
it is done in line with the constitution. And they have ordered the
Constitutional Court to hear the case which is now before the
Constitutional Court pending a hearing by a new panel of judges.
Making health care a priority
The case has contributed to jurisprudence to help people realise their social economic rights in Uganda.
But it has also catalysed improvements in health service provision.
Since the case was initially heard government funding for the health
sector has improved from US$ 215 million (UGX 737.60 billion) to US$ 328
million (UGX 1127.48 billion) and more health workers have been recruited. Mothers, however, are still expected to bring their own “mama kits” when going into labour.
There has also been a reduction in maternal deaths. These have fallen
from 440 deaths for every 100 000 live births in 2010 to 343 by 2015.
Most importantly, civil society organisations are now, more than ever, alert to demanding women’s health care rights. *Primah Kwagala, a human rights lawyer at the Centre for Health,
Human Rights and Development (CEHURD) where she manages strategic
litigation programmes, was integral in the writing of this article.
From Kibale( where Ebola started recently) to
Kabale( where there is a Marburg virus
outbreak): Marburg outbreak confirmed in Western Uganda: The test of biological weapons on African
Guinea pigs is not over yet
I smell a rat but Jesus will always protect the
poor Africans from Man’s wicked schemes !! Strange malaria-like disease hits Uganda: US experts to monitor deadly hemorrhagic
fevers in Uganda: Oh:
really: Why has Uganda
become a home for all kinds of Hepatitis Out breaks ??
Dear Global research.ca , The US invented the Ebola Virus from Bundibugyo, Uganda
that is why they have a patent for their invention. The US’s invention of that virus is not
a claim, it is the truth.
Wickedness in high places : When Ebola creators pretend
to be messianic solvers on their own biological weapon : WHO meets on
experimental Ebola drug use
From Marburg to Ebola, Destructing us from the
exposed rot of Museveni’s US client state regime due to corruption : Ebola
outbreak in Uganda is a mere political game speared headed by the US new world
system to destruct us from the exposed Corruption in Museveni’s regime and the
participation of Uganda in the support of M23 rebels
Ebola as a US neo-imperialistic weapon:
Portray Africans as poor helpless zombies: Come in as a solution to the Ebola
virus you have created : Use this pretext to steal their mineral resources :
Obama: Ebola crisis 'spiraling out of control' : US military to help Ebola
effort
Health officials bury a Marburg victim last year. FILE PHOTO
By Agatha Ayebazibwe
Posted
Monday, October 6
2014 at
01:00
In Summary
The Ministry of Health has dispatched teams of
epidemiologists to Mengo, Mpigi hospitals and Kasese District where the
deceased was treated before his death
Kampala.
The Ministry of Health and the World Health
Organisation yesterday confirmed the outbreak of Marburg Viral fever in
the country after one person died of the disease on September 28.
Laboratory
test results done at Uganda Virus Research Institute confirmed that the
30-year old-man, a health worker at Mengo Hospital, died of Marburg.
The deceased man’s brother, who is also a health
worker at the hospital, has also been quarantined at the facility after
he presented with signs of the disease a few days after the first case
was buried.
Samples have been taken to UVRI for further tests and the results are expected by midday.
According to the Acting Minister for Health, Dr
Elioda Tumwesigye, the ministry has dispatched teams of epidemiologists
to Mengo, Mpigi hospitals and Kasese District where the deceased was
buried last month.
“We are tracing all the possible people that the
deceased may have had contact with for close monitoring for at least 21
days. In the meantime, we call upon the public to remain alert and
report any suspected cases,” Dr Elioda said.
According to a
press statement issued by the ministry, the deceased, who originally
worked at Mpigi Health Centre IV, had been recruited by Mengo Hospital
two months ago as a radiographer.
“He started feeling unwell on September 17 while
at Mengo Hospital and travelled back to Mpigi HCIV on September 18 to
seek treatment since he felt more comfortable with a facility that he
had worked with for a long time,” reads the statement.
He was treated at Mpigi Health Centre IV but when
his condition worsened, he was transferred back to Mengo where he was
admitted on September 23.
He presented with headache, bleeding from different body openings, abdominal pain, vomiting blood and diarrhoea.
He passed away on September 28 and his body was taken to Munkunyu village, Munkunyu Sub-county, Kasese for burial.
The minister said 80 people who got into contact
with the initial confirmed case have been identified and isolated as a
precautionary measure and for follow up for any signs and symptoms
within the 21 days incubation period of the disease.
“They are
currently being monitored by a team of epidemiologists from the Ministry
of Health,” Dr Tumwesigye said while addressing the media yesterday in
Kampala.
The WHO Country Representative, Dr Alemu
Wondimagegnehu, said the public should not be frightened, necessary
precautionary measures have been put in place to cantain the spread of
the disease.
“There is no reason to panic. A team of experts has been
put together to assess the situation where the deceased was treated,”
Dr Wondimagegnehu said.
about marburg fever
Cause.
Marburg Viral Haemorraghic fever is a fatal
illness caused by the Marburg virus which belongs to the same family
together with the Ebola virus.
Incubation.
The incubation period ranges from two to 21 days
while the case fatality rate varies from 24 to 88 per cent. The Marburg
virus is transmitted to people from the fruit bats and spreads among
humans through human-to-human transmission by direct contact with wounds
and body fluids like blood, saliva, vomitus, stool and urine of an
infected person.
Marburg: Five more suspects reported, 97 being monitored
An Ebola isolation unit at Mulago Hospital which is being rehabilitated
to accommodate Marburg patients. PHOTO BY RACHEL MABALA
By Agatha Ayebazibwe
Posted
Tuesday, October 7
2014 at
01:00
In Summary
On alert. Marburg samples picked Mpingi District to be examined by the virus institute. P.45 Marburg suspects reported
Kampala. The Ministry of Health
yesterday sent five more samples of the suspected Marburg fever to the
Uganda Virus Research Institute (UVRI) for more tests after they
presented signs of the disease. On Sunday, the ministry confirmed a
health worker had succumbed to the disease following laboratory tests
done on September 30.
The ministry is also awaiting results of a
sample from the deceased’s brother, who has so far been listed as having
developed signs of the deadly disease. He has since been quarantined
and isolated for further monitoring.
According to the World Health
Organisation country representative, Dr Alemu Wondimagegnehu, the five
samples were drawn from people who were in contact with the deceased
while at Mpingi Health Centre IV. “The information we got from the
team on the ground is that the five presented with signs of the disease.
The samples have been delivered at UVRI and results are expected soon,”
Dr Wondimagegnehu told Daily Monitor in an interview.
A temporary isolation centre has been set up at Mpigi Health Centre IV where the suspected cases are being quarantined.
The
permanent secretary in the Ministry of Health, Dr Asuman Lukwago, also
said another 17 contacts have been identified in Kampala, bringing the
total of those who were in contact with the deceased to 97. “Our
teams are still on the ground tracing all the possible contacts. Those
who have been identified will be isolated in their homes for at least 21
days. If they show any signs such as fever and headache, then we take
their samples for further tests,” Dr Lukwago told Daily Monitor.
He added that results of the six samples are expected in a few hours. However,
some officials have expressed concern over the ministry’s preparedness
to handle the crisis, should it become a fully-fledged Marburg outbreak.
“The
confirmatory test results were received at the Ministry of Health on
September 30, but to date, the ministry has not released any money to
facilitate the teams to respond appropriately,” said a source within the
ministry who preferred to remain anonymous.
But Dr Lukwago said they
are still treating the matter as an emergency, saying those involved
can use their money which will be refunded once the ministry gets the
money.
“We are aiding them with things such as fuel, cars to enable
them move from one place to another. We also expect to have a costed
plan for the response in the next 36 hours,” he added.
About the disease Cause.
Marburg Viral Haemorraghic fever is caused by the Marburg virus which
belongs to the same family together with the Ebola virus. The
incubation period ranges from two to 21 days while the case fatality
rates vary from 24 per cent to 88 per cent..
Spread. Fruit bats of
the Pteropodidae family are considered to be the hosts of Marburg. The
virus spreads among humans through human-to-human transmission by direct
contact with wounds and body fluids. Symptoms. Headache, vomiting
blood, joint and muscle pains, bleeding through the body openings, such
eyes, nose, gums, ears, anus and the skin.
US experts to monitor deadly hemorrhagic fevers in
Uganda
The United States
Department of Defense is partnering with the health ministry to improve
regional surveillance of deadly hemorrhagic fevers such as Marburg and
Ebola.
This was revealed Thursday by the health ministry’s Permanent Secretary,
Dr. Asuman Lukwago, during the occasion to hand over 19 vehicles to
facilitate monitoring and evaluation of health activities in the
country.
Lukwago said a team of experts from the US Defense Department had
already touched base in the country and was setting up structures on
effective monitoring and control of the deadly fevers.
He said they are going to put epidemiologists (health experts) in every
region of the country to constantly be on the lookout for any outbreak.
“In case any disease breaks up, these epidemiologists will be able to detect it very fast,” said Lukwago.
He said they were also working with the Uganda Virus Research Institute
(UVRI) in Entebbe and the US Centres for Disease Control and Prevention
(CDC) so for any disease outbreak, samples can be taken at the Institute
and diagnosis done quickly.
A statement from the CDC, also released yesterday, read that preventing,
detecting and responding to outbreaks as early and effectively as
possible was necessary to keep the world safe and secure from infectious
disease threats.
The statement indicated that the CDC has been partnering with the health
ministry to effectively monitor and control the deadly pathogens for
the last six months. And that the partnership had resulted in
improvements in disease detection and response.
Uganda has had its share of the deadly pathogens, the prominent cases
being of Ebola and the Marburg virus which killed scores of people in
Kabale district in 2012.
State
Minister for Health, Elioda Tumwesigye (left) and Director General of
health services, Jane Ruth Aceng addressing the press in Kampala.
PHOTO BY LAWRENCE KITATTA
By Vision Reporter The Ministry of Health has today announced one fatal case of Marburg disease. The victim is a 30 year old health worker.
The victim had been a radiographer, or X-ray technician, at the Mpigi
Health Centre IV, but was recruited two months ago for a similar
position at Mengo Hospital. When he felt ill on September 17, he
traveled back to Mpigi for treatment since “he felt more confortable
with a facility that he had worked with for a long time.”
Marburg is one of the five members of the family of filoviruses, to
which Ebola belongs. Like Ebola, a person infected with Marburg will
experience a sudden onset of fever.
The most common additional signs are headache, joint and muscle
pains, vomiting blood, and bleeding through body openings. The disease
has a two to 21-day incubation period and, like Ebola, has no cure other
than supportive treatment.
Today’s statement from Elioda Tumwesigye, Minister of State for
General Duties & Holding the Portfolio of Minister for Health,
describes a total of 80 people who were in contact with the man have
been identified and isolated to follow for signs and symptoms.
President Yoweri Museveni immediately called for vigilance. "The
Ministry of health is tracing all the people including relatives who may
have been in close contact. Please report suspicious cases," Museveni
said on twitter.
"Stay calm but vigilant. Avoid shaking hands and cooperate with health workers."
Prime Minister Ruhakana Rugunda reassured the country of measures to control the disease.
"Marburg is a Viral Hemorrhagic fever caused by the Marburg virus.
Ministry of Helath has put in place rigorous surveillance and disease
control measures. Uganda has experience and adequate capacity to deal
with this health threat & World Health Organisation has been
informed," Prime Minister Ruhakana Rugunda said.
"The public has also been alerted to report any suspected cases on the Ministry hotline on +256750996034, " he added.
"Uganda has previously successfully handled similar situations of health threats involving Hemorrhagic fevers." FULL STATEMENT Ministry of Health Press Statement on confirmed Marburg Fever death The Ministry of Health would like to inform the general public that there is a confirmed case of Marburg in the country. This initial case follows laboratory tests done at the Uganda
Virus Research Institute (UVRI) on September 30th 2014 which confirmed
that one person, a health worker, had died of the viral hemorrhagic
fever.
The index case is a 30-year-old male Radiographer, who
originally was working in Mpigi Health Centre IV, Mpigi Town Council but
had been recruited by Mengo Hospital two month ago as a Radiographer.
He started feeling unwell on September 17th while at Mengo Hospital and
travelled back to Mpigi HCIV on September 18th to seek treatment since
he felt more comfortable with a facility that he had worked with for a
long time. He was treated at Mpigi Health Center IV but when his
condition worsened, he was transferred back to Mengo Hospital where he
was admitted on September 23rd. He presented with Headache, Epistaxis,
abdominal pain, vomiting blood and diarrhea. His condition deteriorated
on September 27th and a Viral Haemorraghic fever was suspected. Blood
samples were removed for further analysis on September 28th;
unfortunately he died on the same day. His body was taken to Munkunyu 1
Village, Munkunyu Sub-county, Kasese district for burial. Preliminary reports also show that his brother, one of
the contacts so far listed has developed signs. He has been quarantined
and isolated for further monitoring. Samples have been taken from him
and are being tested at the Uganda Virus Research Institute. The public
will be informed of his status. Altogether 80 contacts have been listed
from Mengo, Mpigi and Kasese for follow up. Marburg Viral Haemorraghic fever is a fatal illness
caused by the Marburg virus which belongs to the filoviridae family
together with the Ebola virus. The incubation period ranges from 2 to 21
days while the Case fatality rates vary from 24% to 88%. Fruit bats of
the Pteropodidae family are considered to be the natural hosts of
Marburg virus. The Marburg virus is transmitted to people from the fruit
bats and spreads among humans through human-to-human transmission by direct contact with wounds and body fluids like blood, saliva, vomitus, stool and urine of an infected person. A person suffering from Marburg presents with sudden onset of high fever with any of the following; 1. Headache 2. Vomiting blood 3. Joint and muscle pains 4. Bleeding through the body openings, i.e. eyes, nose, gums, ears, anus and the skin. There is no specific antiviral treatment or vaccine available; patients are usually given supportive treatment.
The Ministry of Health is undertaking the following measures to control the spread of the disease; • Yesterday, a team of epidemiologists and surveillance
officers were sent to Mpigi Health Center IV, Mengo Hospital and to
Kasese district to investigate the case and list all people who got into
contact with the dead. • So far, a total of 80 people who got into contact with the
initial confirmed case have been identified and isolated as a
precautionary measure and for follow up for any signs and symptoms
within the 21 days incubation period. These include 38 health workers
from Mengo Hospital, including his brother and 22 health workers from
Mpigi Health Center IV and 20 people from Kasese district. They are
currently being monitored by a team of epidemiologists from the Ministry
of Health. • Arrangements have been put in place to transport all
suspect cases to the National Isolation Facility in Entebbe should they
occur. The facility is already stocked with the necessary infection
control materials and other supplies to handle any incoming patients. • Arrangements have also been made at Mengo Hospital to
isolate any suspect with symptoms. Health workers have been asked to
effect all infection control measures. • Preparations are underway to train all health workers at
Mengo Hospital and Mpigi Health Center IV on infection control starting
tomorrow 6/10/2014 at 9.00am • Government working with partners and specifically Medicens
San Frontiers (MSF) are in the process of revamping the isolation
facility at Mulago National Referral Hospital under the leadership of
Kampala Capital City Authority in readiness and the facility will be
ready in three days time. • MSF is also mobilizing additional resources to assist with
infection control and case management at all the isolation facilities
that have been set up. • The World Health Organization (WHO) is providing technical
assistance and logistical support (PPE’s) to all the affected
facilities. • In Kasese, a team has been dispatched to work with the
district official and Kagando Hospital to trace for any other suspects. • Personal Protective Equipments (PPE’s) and other supplies
have been mobilized and sent to Mengo and Mpigi health center IV and
Kagando HCIV. • National Medical Stores will supply additional infection
control materials to Mengo Hospital and Mpigi HCIV by tomorrow morning. The Ministry of Health however informs the general Public
that Mengo Hospital is safe and all measures have been taken to ensure
that there is no further spread of infection. Patients are encouraged to
continue to receive services from there. Ministry of Health urges the general public to observe the following protective measures; • Report any suspected patient to a nearby health unit • Avoid direct contact with body fluids of a person presenting with bleeding tendencies or symptoms of Marburg. The Ministry of Health once again calls upon the public to
remain calm and be on alert amidst this epidemic. All suspect cases can
be reported on the Ministry hotline on +256750996034.
Hon. Elioda Tumwesigye
Minister of State for General Duties &
Holding the Portfolio of Minister for Health
Hillary Clinton’s messianic entry into Uganda
amidst the politics of Ebola scare: US’ Hillary starts Africa tour, here
in Uganda tomorrow: Washington says Ms Clinton’s meeting with
Museveni on Friday will focus on regional security, human rights and
democracy:
Oh! Really
The evil that humans do: Ebola Kills 14 in
Kibale District of Uganda:
Locals believed the illnesses were the result of an attack of evil spirits,
send the sick for prayers
The ministry of Health has confirmed three
new cases of Ebola Virus Disease, bringing the total number of
confirmed infections recorded in Uganda to five.
The new cases include a Ugandan driver who
transported the country’s first confirmed patient and later succumbed
to complications linked to the disease, as well as a health worker who
had been involved in managing the patient.
According to Dr Charles Olaro, the
director general of health services, the third new case involves a
Congolese woman who entered Uganda through the Arua border before
travelling to Entebbe.
A statement from the ministry of Health
indicates that the woman used a chartered flight from Arua to Entebbe
and later sought treatment at a private hospital in Kampala.
The hospital reportedly discharged the
woman, who subsequently travelled back to the Democratic Republic of
Congo (DRC). However, samples taken by Ugandan authorities later
returned positive for Ebola after she had already left the country.
The latest infections come as Ugandan authorities continue to contest
the World Health Organization’s decision to classify Uganda together
with the DRC in the current outbreak response, despite Uganda having
recorded only a handful of confirmed cases compared to the dozens of
infections and deaths reported across the border.
Addressing a press conference on Thursday,
Dr Diana Atwine, permanent secretary at the ministry of Health,
announced restrictions on travel to the DRC, arguing that Uganda had not
registered active positive cases at the time because the only imported
patient receiving treatment in the country had tested negative.
Meanwhile, the United States earlier this
week updated its travel advisory, warning Americans against travelling
to the DRC, South Sudan and Uganda, while advising travellers to
reconsider trips to Rwanda because of the Ebola Bundibugyo Virus Disease
outbreak in the region.
“The Department’s Travel Advisories for
DRC, South Sudan, and Uganda are now Level 4 – Do Not Travel, and the
Travel Advisory for Rwanda is Level 3 – Reconsider Travel,” the notice
on the U.S. Embassy website stated.
One American who had travelled to the DRC tested positive for Ebola and was later evacuated to Germany for treatment.
The current outbreak involving the
Bundibugyo strain marks the second such outbreak to be recorded in both
Uganda and the DRC. Both countries have previously experienced multiple
Ebola outbreaks linked to the Zaire strain.
Health experts warn that the Bundibugyo
strain remains a significant public health threat, particularly because
there are currently no approved vaccines or specific therapeutics
targeting it. Treatment efforts largely rely on supportive care, while
the fatality rate for the disease is estimated at about 40 per cent.
Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda
On 5 May 2026, the World Health Organization (WHO) was
alerted of a high-mortality outbreak of unknown illness in Mongbwalu
Health Zone, Ituri Province, Democratic Republic of the Congo (DRC),
including deaths among health workers.
On 14 May 2026, the Institut national de recherche biomédicale (INRB)
Kinshasa analyzed 13 blood samples from Rwampara Health Zone, Ituri
Province. Laboratory analysis confirmed Bundibugyo virus disease (BVD)
in eight of these samples on 15 May, a species of Ebola.
The case fatality rates in the past two BVD outbreaks have ranged from
30% to 50%. Unlike Ebola virus disease, there is no licensed vaccine or
specific therapeutics against Bundibugyo virus, though early supportive
care is lifesaving.
On 15 May 2026, the Ministry of Public Health, Hygiene and Social
Welfare, DRC, officially declared the 17th Ebola Disease outbreak in
DRC. Concurrently, the Uganda Ministry of Health confirmed an outbreak
of BVD following the identification of one imported case from DRC, a
Congolese man who died in the capital city of Kampala.
On 16 May 2026, WHO Director-General, after having consulted the States
Parties where the event is known to be currently occurring, determined
that the Ebola disease caused by Bundibugyo virus in DRC and Uganda
constitutes a public health emergency of international concern (PHEIC),
as defined in the provisions of IHR.
Response measures include deployment of rapid response teams, delivery
of medical supplies, strengthened surveillance, laboratory confirmation,
infection prevention and control assessments, the set-up of safe
treatment centers, and community engagement. WHO is supporting the
coordination of the response, case management, and cross-border
preparedness. WHO advice has been issued to countries.
Description of the situation
On 5 May 2026, WHO received an alert regarding an unknown
illness with high mortality reported in Mongbwalu Health Zone, Ituri
Province, including four health workers who died within four days.
Following an in-depth investigation by the rapid response team in
Mongbwalu and Rwampara health zones (HZ) on 13 May, the outbreak was
subsequently confirmed as Bundibugyo virus disease (BVD) due to
Bundibugyo virus (BDBV) (Orthoebolavirus bundibugyoense, species) on 15 May.
On 15 May 2026, the Ministry of Public Health, Hygiene and Social Welfare officially declared the 17th Ebola Disease outbreak in the DRC, occurring in Rwampara, Mongwalu and Bunia HZ.
The
first currently known suspected case, a health worker, reported onset
of symptoms including fever, hemorrhaging, vomiting and intense malaise
on 24 April 2026. The case died at a medical centre in Bunia.
As
of 15 May, a total of 246 suspected cases and 80 deaths (four deaths
among confirmed cases) have been reported from three HZ: Rwampara (six
health areas affected), Mongbwalu (three health areas affected), and
Bunia . Twenty four suspected cases are currently in isolation
facilities across the three HZ. In addition, unusual clusters of
community deaths with symptoms compatible with Bundibugyo virus disease
(BVD) are being investigated across other HZ in Ituri and North Kivu.
A
further case reported on 16 May, an individual returning from Ituri to
Kinshasa, has tested NEGATIVE for Bundibugyo virus on confirmatory
testing by the Institut National de la Recherche Biomédicale (INRB) of
DRC, and is therefore not considered a confirmed case.
Most of
the suspected cases are between 20 and 39 years old, with females
accounting for over 60%, suggesting significant risks associated with
household and caregiver transmission.
Initial testing of 20
samples collected in Rwampara HZ and analysed at the Provincial Public
Health Laboratory in Bunia using standard Ebola Xpert were negative for
Ebola virus. Samples were sent to INRB for further analysis, of which
eight samples analysed were confirmed as Orthoebolavirus by polymerase chain reaction (PCR) on 15 May. Genomic sequencing confirmed the virus species as Bundibugyo virus (BDBV).
As
of 15 May, 65 contacts have been listed, with 15 identified as
high-risk. However, follow-up remains weak due to insecurity and
movement restrictions. Several listed contacts became symptomatic and
died before they could be isolated.
On 15 May 2026, the
Ministry of Health of Uganda confirmed an outbreak of BVD following the
identification of an imported case from the DRC. The case is an elderly
man who was admitted to a private hospital on 11 May with severe
symptoms and died on 14 May. The post-mortem transfer of the body to DRC
was completed the same day. A clinical sample collected when the case
was admitted on 11 May was tested at the Central Emergency Surveillance
and Response Support Laboratory, Wandegeya, and was confirmed as
Bundibugyo virus on 15 May 2026. A second imported case was confirmed on
16 May in Kampala, in an individual returning from DRC with no apparent
links to the first case. At the time of reporting, no local
transmission has been identified in Uganda.
On 16 May 2026, the
Director-General of WHO, after having consulted the States Parties where
the event is known to be currently occurring as defined in the
provisions of the International Health Regulations (2005) (IHR),
determined that the Ebola disease caused by Bundibugyo virus in DRC and
Uganda constitutes a PHEIC.
It is currently thought that the event
originated in the Mongbwalu HZ, DRC, a high-traffic mining area, with
cases subsequently migrating to Rwampara and Bunia to seek medical care.
Ituri province borders South Sudan and Uganda (and Bunia HZ is less
than 500km from Uganda). A full epidemiological investigation and trace
back exercise is ongoing.
Ituri’s role as a commercial and
migratory hub and proximity to Uganda and South Sudan increases the risk
of regional exportation and cross-border transmission.
Figure 1. Health Zones affected by Bundibugyo virus disease in Democratic Republic of Congo, as of 16 May 2026
Epidemiology
Bundibugyo virus disease (BVD) is a severe and often fatal form of Ebola disease caused by the Bundibugyo virus, one of the Orthoebolavirus species.
It is a zoonotic disease, with fruit bats suspected to be the natural
reservoir. Human infection occurs through close contact with the blood
or secretions of infected wildlife, such as bats or non-human primates,
and subsequently spreads from person to person through direct contact
with the blood, secretions, organs, or other bodily fluids of infected
individuals or contaminated surfaces. Transmission is particularly
amplified in health-care settings when infection prevention and control
(IPC) measures are inadequate, and during unsafe burial practices
involving direct contact with the deceased.
The incubation period
for BVD ranges from 2 to 21 days, and individuals are usually not
infectious until symptom onset. Early symptoms are non-specific,
including fever, fatigue, muscle pain, headache, and sore throat, which
complicates clinical diagnosis and can delay detection. These progress
to gastrointestinal symptoms, organ dysfunction, and in some cases
haemorrhagic manifestations. Case fatality rates in the past two BVD
outbreaks, reported in Uganda and in DRC in 2007 and 2012, have ranged
from approximately 30% to 50%.
Differentiating BVD from other
endemic febrile illnesses such as malaria is challenging without
laboratory confirmation using PCR or antigen/antibody-based assays.
Control relies on rapid case identification, isolation and care, contact
tracing, safe burials, and strong community engagement, as no approved
vaccines or specific treatments currently exist for BVD.
Public health response
Health authorities in DRC are implementing public health measures, including but not limited to the following:
Coordination
Rapid response teams have been deployed to Rwampara and Mongbwalu HZ.
Provincial coordination andemergency meetings by le centre d’operation des urgences en sante publique (COUSP) have been held.
Surveillance and Laboratory
Surveillance for suspected and probable cases is ongoing (including at relevant Points of Entry and borders).
Operational case definitions have been elaborated in Ituri.
Sequencing confirmed Bundibugyo virus in positive RT-PCR samples.
Risk Communication and Community Engagement (RCCE)
Social mobilization meeting was held with community leaders in the Rural commune of Mongbwalu under the leadership of the Mayor.
Infection Prevention and Control (IPC)
IPC
assessment in key health facilities is ongoing: Bunia Hospital Centre
of the Evangelical Medical Centre (CME), Mongbwalu General Referral
Hospital and Abelkozo Health Centre.
CME Bunia is maintaining
isolation protocols. Healthcare workers have been briefed on the
specific diagnostic profile of this strain.
Logistics
Logistical support has been provided for investigations in Mongbwalu and Rwampara Health Zones.
Support has been provided for the transportation of samples to INRB Kinshasa.
Health authorities in Uganda are implementing public health measures, including but not limited to the following:
Activating
national and district-level emergency measures, including enhanced
surveillance, screening at borders, deployment of rapid response teams,
isolation of a high-risk contact, and quarantine of all identified
contacts.
Strengthening of preparedness activities such as mobile laboratory deployment, infection prevention, and risk communication.
Rapid
response readiness teams have been deployed at all official and
informal points of entry along the western border, major transit routes,
and pilgrimage corridors.
Advising health workers to remain vigilant and adhere strictly to infection prevention measures.
WHO is supporting the national authorities, including through:
Deployment of technical expertise and rapid response teams to support response efforts.
Deployment of IPC, clinical management and sample collection kits.
Identification of isolation facilities for case management in Bunia, Rwampara, and Mongbwalu HZ .
Dissemination of WHO case management protocol.
In-depth investigations and listing of contacts of suspected/probable cases.
Strengthening epidemiological surveillance, IPC and RCCE at all points of entry.
Strengthening Point of Entry (PoE) screening and cross border coordination, including mass gatherings.
Supporting the Ministry of Health in implementation of the Response Plan and WHO internal Response Plan.
Following
up with the IHR National Focal Points (IHR NFP) in DRC and Uganda on
the official IHR notification while concurrently managing communication
across the IHR NFP network to ensure timely coordination.
Coordinating the delivery of key supplies.
Engaging experts on research and development priorities.
WHO risk assessment
On 16 May 2026, WHO Director-General, after having
consulted the States Parties where the event is known to be currently
occurring, determined that the Ebola disease caused by Bundibugyo virus
in the Democratic Republic of the Congo and Uganda constitutes a public
health emergency of international concern (PHEIC), as per the provisions
of the IHR. Temporary recommendations for State Parties will be issued.
In the meantime, WHO issued advice to countries, as stated below.
This
is the 17th Ebola disease outbreak in the DRC since 1976. The last
Ebola disease outbreak in the country was declared on 4 September 2025
with total of 64 cases (53 confirmed, 11 probable), including 45 deaths
(CFR 70.3%), reported from six health areas in Bulape Health Zone, Kasai
Province. The end of outbreak was declared on 1 December 2025. The last
BVD outbreak was reported on 17 August 2012 by the DRC Ministry of
Health in Province Orientale. A total of 59 cases, 38 confirmed and 21
probable cases, including 34 deaths were reported. The outbreak was
declared over on 26 November 2012 by the MOH.
This outbreak
is occurring in a complex epidemiological and humanitarian context. A
critical four-week detection gap between the onset of symptoms of the
presumed index case (25 April 2026) and the laboratory confirmation of
the outbreak (14 May 2025) suggests a low clinical index of suspicion
among healthcare providers. This is compounded by the presence of
co-circulating arboviruses and influenza-like illnesses, masking the
initial index of suspicion for Ebola disease and exacerbating community
transmission. Furthermore, the infection and death of four healthcare
workers within a four-day span at Mongbwalu General Referral Hospital
underscores critical breaches in IPC protocols. A large number of
community deaths has been reported potentially associated with unsafe
burial practices.
Ongoing conflict in Ituri province
restricts the movement of surveillance teams, limits the deployment of
Rapid Response Teams, and hinders the secure transport of laboratory
samples. Contact tracing is challenging due to difficult access and
highly mobile populations, increasing the risk of high-risk contacts
being lost to follow up or never identified.
Ituri’s role as a
commercial and migratory hub increases the risk of regional
exportation. The proximity to Uganda and South Sudan increases the risk
of cross-border transmission if PoE screening and cross border
coordination and information sharing are not immediately reinforced. On
15 May 2026, the Ministry of Health of Uganda reported an imported case
of BVD.
Humanitarian needs in the area are dire. Ituri has
273 403 displaced people, with a total of 1.9 million people in need
according to the Humanitarian Response Plan 2026 for DRC. From January
to March 2026, 32 600 newly displaced and 30 200 returnees were
recorded. The province recorded 5800 protection incidents and 11
incidents against humanitarian actors.
Unlike Ebola virus disease,
there is no licensed vaccine or specific therapeutics against BDBV.
Research and development activities are activated to coordinate efforts
to advance potential candidate medical countermeasures. Response and
outbreak control relies entirely on a range of interventions and public
health measures that will need to be thoroughly implemented, including
supportive care, early detection, adequate IPC, rigorous contact
tracing, safe burials, and community engagement.
WHO advice
For countries where the event is occurring (the Democratic Republic of the Congo and Uganda)
Coordination and high-level engagement
Activate
their national disaster/emergency management mechanisms and establish
an emergency operation centre, under the authority of the Head of State
and relevant government authority, to coordinate response activities
across partners and sectors to ensure efficient and effective
implementation and monitoring of comprehensive Bundibugyo virus disease
control measures. These measures must include enhanced surveillance
including contact tracing, infection prevention and control (IPC), risk
communication and community engagement, laboratory diagnostic testing,
and case management. Coordination and response mechanisms should be
established at national level, as well as at subnational level in
affected areas and at-risk areas.
Should national
capacities be overwhelmed, collaboration with partners should be
enhanced to strengthen operations and ensure the ability to implement
control measures in all affected and neighbouring areas.
Risk communication and community engagement
Ensure
that there is a large-scale and sustained effort to fully engage the
community – through local, religious and traditional leaders and healers
– so communities play a central role in case identification, contact
tracing and risk education; the population should be made fully aware of
the benefits of early treatment.
Strengthen community
awareness, engagement, and participation in particular to identify and
address cultural norms and beliefs that serve as barriers to their full
participation in the response, and integrate the response within the
wider response required to address the needs of the population,
particularly in contexts of the protracted humanitarian crisis in
Eastern DRC.
Surveillance and laboratory
Strengthening
surveillance and laboratory capacity across affected provinces and
neighbouring provinces, through the establishment of (1) dedicated
surveillance and response cells within affected health zones and across
key at-risk neighbouring health zones; (2) enhanced community
surveillance, particularly focused on community deaths; and (3)
decentralized laboratory capacity for testing of Bundibugyo virus.
Infection prevention and control in health facilities and in the context of care
Strengthen
measures to prevent nosocomial infections, including systematic mapping
of health facilities, triage, targeted IPC interventions and sustained
monitoring and sustained supervision.
Ensure healthcare workers
receive adequate training on IPC, including the proper use of PPE, and
that health facilities have appropriate equipment to ensure the safety
and protection of their staff, their timely payment of salaries and, as
appropriate, hazard pay.
Patients’ referral pathway and access to safe and optimized intensive care.
Ensure
that suspected cases can be safely transferred to specialized clinical
units for their isolation and management in a human and patient-centred
approach.
Establish specialized treatment centers or units,
located close to outbreak epicenter(s), with staff trained and equipped
to implement optimized intensive supportive care.
Research and development of medical countermeasures
Implement clinical trials to advance the development and use of candidate therapeutics and vaccine, supported by partners.
Border health, travels and mass-gathering events
Undertake
cross-border screening and screening at main internal roads to ensure
that no suspected case is missed and enhance the quality of screening
through improved sharing of information with surveillance teams.
There
should be no international travel of Bundibugyo virus disease contacts
or cases, unless the travel is part of an appropriate medical
evacuation. To minimize the risk of international spread of Bundibugyo
virus disease:
Confirmed
cases should immediately be isolated and treated in a Bundibugyo virus
disease Treatment Centre with no national or international travel until
two Bundibugyo virus-specific diagnostic tests conducted at least 48
hours apart are negative;
Contacts (which do not include
properly protected health workers and laboratory staff who have had no
unprotected exposure) should be monitored daily, with restricted
national travel and no international travel until 21 days after
exposure;
Probable and suspect cases should immediately be
isolated and their travel should be restricted in accordance with their
classification as either a confirmed case or contact.
Implement
exit screening of all persons at international airports, seaports and
major land crossings, for unexplained febrile illness consistent with
potential Bundibugyo virus disease. The exit screening should consist
of, at a minimum, a questionnaire, a temperature measurement and, if
there is a fever, an assessment of the risk that the fever is caused by
Bundibugyo virus disease. Any person with an illness consistent with
Bundibugyo virus disease should not be allowed to travel unless the
travel is part of an appropriate medical evacuation.
Consider postponing mass gatherings until BVD transmission is interrupted.
Safe and dignified burials
Ensure
funerals and burials are conducted by well-trained personnel, with
provision made for the presence of the family and cultural practices,
and in accordance with national health regulations, to reduce the risk
of Bundibugyo virus infection. The cross-border movement of the human
remains of deceased suspect, probable or confirmed Bundibugyo virus
disease cases should be prohibited unless authorized in accordance with
recognized international biosafety provisions.
Operations, supplies and logistics
Strong
supply pipeline needs to be established to ensure that sufficient
medical and laboratory commodities and other critical items, especially
personal protective equipment (PPE), are available to those who
appropriately need them. WHO advises against any restrictions on travel
and/or trade to DRC or Uganda based on available information for the
current outbreak.
For countries with land borders adjoining countries with documented Bundibugyo virus disease
Unaffected
States Parties with land borders adjoining States Parties with
documented Bundibugyo virus disease transmission should urgently
enhance their preparedness and readiness capacity, including active
surveillance across health facilities with active zero reporting,
enhancement of community surveillance for clusters of unexplained
deaths; establish access to a qualified diagnostic laboratory; ensure
that health workers are aware of and trained in appropriate IPC
procedures; and establish rapid response teams with the capacity to
investigate and manage BVD cases and their contacts.
Dedicated
coordination mechanisms should be in place at national and subnational
level in all Unaffected States Parties with land borders adjoining
States Parties with documented cases of Bundibugyo virus disease. States
should be prepared to detect, investigate, and manage Bundibugyo virus
disease cases; this should include assured access to a qualified
diagnostic laboratory for Bundibugyo virus disease, isolation and case
management capacity and activation of rapid response teams.
Any
State Parties newly detecting a suspected or confirmed Bundibugyo virus
disease case or contact, or clusters of unexplained deaths should treat
this as a health emergency, take immediate steps in the first 24 hours
to investigate and stop a potential outbreak by instituting case
isolation, case management, establishing a definitive diagnosis, and
undertaking contact tracing and monitoring as required.
If
Bundibugyo virus disease is confirmed to be occurring in the State
Party, the full recommendations for State Parties with Bundibugyo virus
disease transmission should be implemented, on either a national or
subnational level, depending on the epidemiologic and risk context.
State Parties should immediately report the confirmation of Bundibugyo
virus disease to WHO.
Risk communications and community engagement, especially at points of entry, should be increased.
At-risk countries should put in place approvals for investigational therapeutics as an immediate priority for preparedness.
For all other countries
No
country should close its borders or place any restrictions on travel
and trade. Such measures are usually implemented out of fear and have no
basis in science. They push the movement of people and goods to
informal border crossings that are not monitored, thus increasing the
chances of the spread of disease. Most critically, these restrictions
can also compromise local economies and negatively affect response
operations from a security and logistics perspective.
National
authorities should work with airlines and other transport and tourism
industries to ensure that they do not exceed WHO’s advice on
international traffic.
States Parties should provide travelers
to Bundibugyo virus disease affected and at-risk areas with relevant
information on risks, measures to minimize those risks, and advice for
managing a potential exposure.
The general public should be
provided with accurate and relevant information on the Bundibugyo virus
disease outbreak and measures to reduce the risk of exposure.
State
Parties should be prepared to facilitate the evacuation and
repatriation of nationals (e.g. health workers) who have been exposed to
Bundibugyo virus disease.
Entry screening at airports or other
ports of entry outside the affected region are not considered needed
for passengers returning from areas at risk.
Infection
prevention and control and water, sanitation and hygiene in health
facilities during Ebola or Marburg disease outbreaks: rapid
assessment tool, user guide https://www.who.int/publications/i/item/9789240107205